Competent Immune Responses to SARS-CoV-2 Variants in Older Adults Following Two Doses of mRNA Vaccination

Researchers analyzed humoral and cellular immunity against an early-pandemic viral isolate and compare that to the P.1 and B.1.617.2 variants in two cohorts of mRNA vaccine recipients.